David Cristina

Principal

2023 - Current

Executive Director

2019 - 2023

Senior Investment Director

2017 - 2019

Principal (Secondee)

2021 - 2022

Board Observer

2017 - 2017

Proterris is a P2 clinical-stage firm that has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.

Member Board Of Directors

2016 - 2017

Tonic App is a digital health company developing a tool for optimal communication between clinicians.

Member Board of Directors

2015 - 2017

Lymphact is developing unique gamma-delta T-cell based therapeutics in the immuno-oncology field.

Member Board Of Directors

2015 - 2017

Immunethep developed a platform immunotherapy, based on robust and groundbreaking science, that dramatically reduces virulence across a wide range of bacterial strains responsible for serious and life-threatening infections.

Senior Investment Consultant

2015 - 2017

Portugal Ventures is, currently, the largest Venture Capital operator in Portugal, focused on early stage (seed) investments. David's current focus is on: - Evaluating investment opportunities in the Portuguese Life Sciences and MedTech Space. - Accompanying invested companies through the investment cycle.

Co Founder

2012 - 2015

Triple Helix Technologies, Lda (THT), is a boutique consultancy catering to research institutions, offering services in grant sourcing and management, technology transfer and intellectual property protection. David Cristina, during his time at THT has been mostly responsible for the technology transfer and intellectual property areas, having worked on several engaging projects, namely: - Managed a significant IP portfolio (valued at over 1 M euros) - Oversaw patent protection for market-oriented clinical technology - Wrote several business plans, two of which went on to attract over 500.000 euros in seed financing - Designed and implemented the IP policy for two separate research institutions

Member of Cabinet (Adjunto)

2011 - 2015

Initially co-nominated between the Secretary of State for Entrepreneurship and Innovation, Dr. Carlos Oliveira and the Secretary of State for Science, Dra Leonor Parreira. David's main focus is on policies affecting the interface between research and innovation.